Literature DB >> 9581809

IgA Fc receptor (CD89) activation enables coupling to syk and Btk tyrosine kinase pathways: differential signaling after IFN-gamma or phorbol ester stimulation.

P Launay1, A Lehuen, T Kawakami, U Blank, R C Monteiro.   

Abstract

IgA Fc receptors (Fc alphaR) can mediate a variety of inflammatory responses. It has been demonstrated that the FcRgamma subunit is critical in mediating signaling through Fc alphaR. We show that aggregation of Fc alphaR on U937 cells and blood neutrophils results in tyrosine phosphorylation of several intracellular proteins, including the FcR gamma subunit, p72syk, and Bruton tyrosine kinase (Btk). Syk was found to be associated with Fc alphaR and its phosphorylation was increased in phorbol myristate acetate (PMA)- and interferon-gamma (IFN-gamma)-treated U937 cells. In contrast, phosphorylation of Btk was only detected after cell treatment with PMA but not IFN-gamma. These data indicate that signaling through Fc alphaR gamma2 involves at least two subfamilies of tyrosine kinases, syk and Btk. Our results also suggest that activation of tyrosine kinase pathways through Fc alphaR depends on the activation state of the cell. This may be an important regulatory mechanism in IgA-mediated responses at inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581809     DOI: 10.1002/jlb.63.5.636

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross-linking of fcalpha receptors (FcalphaR) with a monoclonal antibody, MIP8a.

Authors:  W Zhang; B Bi; R G Oldroyd; P J Lachmann
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

Review 2.  The role of IgA and IgA Fc receptors as anti-inflammatory agents.

Authors:  Renato C Monteiro
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 3.  Role of IgA and IgA fc receptors in inflammation.

Authors:  Renato C Monteiro
Journal:  J Clin Immunol       Date:  2009-10-16       Impact factor: 8.317

4.  The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.

Authors:  Daniel Paris; Ghania Ait-Ghezala; Corbin Bachmeier; Gary Laco; David Beaulieu-Abdelahad; Yong Lin; Chao Jin; Fiona Crawford; Michael Mullan
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

Review 5.  DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3zeta family.

Authors:  M J Wilson; J A Lindquist; J Trowsdale
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

6.  IgA Fc receptor (FcalphaR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts.

Authors:  Mark L Lang; Yih-Wen Chen; Li Shen; Hong Gao; Gillian A Lang; Terri K Wade; William F Wade
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

Review 7.  Role of IgA receptors in the pathogenesis of IgA nephropathy.

Authors:  Sebastian M Lechner; Christina Papista; Jonathan M Chemouny; Laureline Berthelot; Renato C Monteiro
Journal:  J Nephrol       Date:  2015-11-14       Impact factor: 3.902

8.  Enhanced Bruton's tyrosine kinase activity in the kidney of patients with IgA nephropathy.

Authors:  Jie Wei; Yan Wang; Xiangming Qi; Yonggui Wu
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

Review 9.  Targeting spleen tyrosine kinase-Bruton's tyrosine kinase axis for immunologically mediated glomerulonephritis.

Authors:  Jin-Shuen Chen; Li-Chien Chang; Shyh-Jer Huang; Chao-Wen Cheng
Journal:  Biomed Res Int       Date:  2014-03-30       Impact factor: 3.411

10.  Phospholipid scramblase 1 amplifies anaphylactic reactions in vivo.

Authors:  Asma Kassas-Guediri; Julie Coudrat; Emeline Pacreau; Pierre Launay; Renato C Monteiro; Ulrich Blank; Nicolas Charles; Marc Benhamou
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.